Scleral Lens Market revenue to hit USD 870 Million by 2035, says Research Nester
January 30, 2024 05:30 ET
|
Research Nester
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The global scleral lens market size is slated to expand at ~8.15% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 870 million...
Presbyopia Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies - Eyenovia, Orasis, Ocuphire Pharma, Visus Therapeutics, LENZ Therapeutics, Glaukos Corporation, AbbVie
September 14, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Presbyopia Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies - Eyenovia, Orasis, Ocuphire Pharma, Visus...
Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas
January 31, 2023 09:00 ET
|
Eyenovia
LAS VEGAS, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in connection with its...
Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology
December 22, 2022 09:01 ET
|
Eyenovia
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) -- While medical devices have seen incredible advancements over the last 100 years, ocular drug delivery systems have seen minimal progress; the standard eye...
EDENLUX Launches Campaign for Otus, the Personal EYE-Trainer
November 17, 2021 00:00 ET
|
EDENLUX
CYPRESS, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Otus, created by EDENLUX, has launched a campaign through Indiegogo. Otus is a personal eye-trainer that is made for the purpose of training...
Presbyopia Pipeline Analysis: Emerging Therapies Continue to Transform Clinical Landscape of Presbyopia
March 10, 2021 20:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 10, 2021 (GLOBE NEWSWIRE) -- Presbyopia Pipeline Analysis: Emerging Therapies Continue to Transform Clinical Landscape of Presbyopia Presbyopia pipeline majorly includes...
Horizon Eye Specialists & LASIK Center Now Offers the First and Only FDA-Approved Trifocal Lens Implant for Cataract Surgery: AcrySof IQ PanOptix
October 15, 2019 10:25 ET
|
Horizon Eye Specialists & LASIK Center
SCOTTSDALE, Ariz., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Horizon Eye Specialists & Lasik Center, the leading comprehensive eye care center in Arizona, today announces it has started offering the...
Refocus Group Readies for Commercialization of VisAbility™ Micro Insert System; Expands Salesforce and Manufacturing Capacity
April 12, 2018 09:05 ET
|
Refocus Group
DALLAS, April 12, 2018 (GLOBE NEWSWIRE) -- Refocus Group, a pioneer in vision-correcting technology, announced today that it has expanded its manufacturing and assembly capacity, and is...
Refocus Group Submits Final Module for Pre-Market Approval of the VisAbility™ Micro Insert System for Presbyopia
December 04, 2017 09:05 ET
|
Refocus Group
DALLAS, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Refocus Group, a pioneer in vision-correcting technology, announced today that it has submitted its final module to the U.S. Food and Drug Administration...
San Diego Ophthalmologist Discusses Latest Investigational Treatment for Presbyopia
June 24, 2014 11:01 ET
|
Gordon-Weiss-Schanzlin Vision Institute
SAN DIEGO, CA--(Marketwired - Jun 24, 2014) - Considered part of the eye's natural aging process, presbyopia is a condition that results in a progressively reduced ability to focus on close...